Overview
Flavio Solca practices in Vienna, Austria. Mr. Solca is rated as a Distinguished expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, Lung Cancer, and NUT Carcinoma.
His clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Squamous Cell Lung CarcinomaMr. Solca isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerMr. Solca isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Adult Soft Tissue SarcomaMr. Solca isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerMr. Solca isExperienced. Learn about Breast Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung CancerMr. Solca isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Solca isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- NUT CarcinomaMr. Solca isExperienced. Learn about NUT Carcinoma.